assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_000210895.1_ASM21089v1	NC_015964	Haemophilus parainfluenzae T3T1, complete genome	1	1917847-1918938	1,1,1,2	PILER-CR,CRISPRCasFinder,CRT,PILER-CR	no	cas9,cas1,cas2	WYL,cas3,DEDDh,csa3,DinG,cas9,cas1,cas2	 Type II-B,Type II-A,Type II-C,Type II-B, or Type II-C?	ATTATAGCACTGCGAAATGAAAAAGGGAGCTACAAC,ATTATAGCACTGCGAAATGAAAAAGGGAGCTACAAC,ATTATAGCACTGCGAAATGAAAAAGGGAGCTACAAC,ATTATAGCACTGCGAAATGAAAAAGGGAGCTACAAC	36,36,36,36	0	0	NA	NA	NA:NA:NA:NA	14,16,16,14	16	TypeII-B,TypeII-A,TypeII-C,TypeII-B,orTypeII-C?	WYL,cas3,DEDDh,csa3,DinG,cas9,cas1,cas2	NA,NA	NA|752aa|up_9|NC_015964.1_1905162_1907418_+	PRK05561, PRK05561, DNA topoisomerase 4 subunit A	NA|405aa|up_8|NC_015964.1_1907454_1908669_+	TIGR00210, Sodium/glutamate_symport_carrier_protein, sodium--glutamate symport carrier (gltS)	NA|435aa|up_7|NC_015964.1_1908724_1910029_-	PRK10846, PRK10846, bifunctional folylpolyglutamate synthase/ dihydrofolate synthase; Provisional	NA|297aa|up_6|NC_015964.1_1910033_1910924_-	PRK05654, PRK05654, acetyl-CoA carboxylase carboxyltransferase subunit beta	NA|265aa|up_5|NC_015964.1_1910989_1911784_-	PRK00021, truA, tRNA pseudouridine(38-40) synthase TruA	NA|96aa|up_4|NC_015964.1_1911887_1912175_-	PRK05943, PRK05943, 50S ribosomal protein L25; Reviewed	NA|202aa|up_3|NC_015964.1_1912401_1913007_+	COG0586, DedA, Uncharacterized membrane-associated protein [Function unknown]	cas9|1053aa|up_2|NC_015964.1_1913334_1916493_+	COG3513, COG3513, Predicted CRISPR-associated nuclease, contains McrA/HNH-nuclease and RuvC-like nuclease domain [Defense mechanisms]	cas1|306aa|up_1|NC_015964.1_1916548_1917466_+	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas2|109aa|up_0|NC_015964.1_1917458_1917785_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	NA|204aa|down_0|NC_015964.1_1919005_1919617_-	PRK13020, PRK13020, riboflavin synthase subunit alpha; Provisional	NA|466aa|down_1|NC_015964.1_1919661_1921059_+	PRK01766, PRK01766, multidrug efflux protein; Reviewed	NA|492aa|down_2|NC_015964.1_1921098_1922574_-	PRK11712, PRK11712, ribonuclease G; Provisional	NA|505aa|down_3|NC_015964.1_1922691_1924206_+	TIGR02121, Osmoregulated_proline_transporter, sodium/proline symporter	NA|322aa|down_4|NC_015964.1_1924205_1925171_+	PRK15068, PRK15068, tRNA 5-methoxyuridine(34)/uridine 5-oxyacetic acid(34) synthase CmoB	NA|271aa|down_5|NC_015964.1_1925285_1926098_+	PRK09687, PRK09687, putative lyase; Provisional	NA|132aa|down_6|NC_015964.1_1926217_1926613_+	sd00045, ANK, ankyrin repeats	NA|363aa|down_7|NC_015964.1_1926663_1927752_-	PRK11760, PRK11760, putative 23S rRNA C2498 ribose 2'-O-ribose methyltransferase; Provisional	NA|298aa|down_8|NC_015964.1_1927744_1928638_-	PRK11139, PRK11139, DNA-binding transcriptional activator GcvA; Provisional	NA|344aa|down_9|NC_015964.1_1929119_1930151_+	PRK13357, PRK13357, branched-chain amino acid aminotransferase; Provisional
